Detalhe da pesquisa
1.
Phase I study of escalating doses of carfilzomib with HyperCVAD in patients with newly diagnosed acute lymphoblastic leukemia.
Am J Hematol;
96(4): E114-E117, 2021 04 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33476436
2.
Management of neutropenic fever during a transition from traditional hematology/oncology service to hospitalist care.
WMJ;
113(2): 53-8, 2014 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24908899
3.
Clinical experience with frontline Hyper-CVAD-based regimens, including Hyper-CVAD plus ponatinib, in patients with acute lymphoblastic leukemia treated at a comprehensive cancer center.
Leuk Res;
119: 106885, 2022 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35738024
4.
Retrospective Analysis of Adult Patients With Relapsed/Refractory Acute Myeloid Leukemia Treated with FLAG at a Comprehensive Cancer Center.
Clin Lymphoma Myeloma Leuk;
21(7): e611-e618, 2021 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33811007
5.
Outcomes of Adults With Relapsed/Refractory Acute Myeloid Leukemia Treated With Venetoclax Plus Hypomethylating Agents at a Comprehensive Cancer Center.
Front Oncol;
11: 649209, 2021.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33777810
6.
A Phase I Study of Everolimus and Bendamustine in Patients With Relapsed/Refractory Lymphoid Hematologic Malignancies.
Clin Lymphoma Myeloma Leuk;
20(7): 453-458, 2020 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32171691
7.
Allogeneic hematopoietic cell transplantation using non-myeloablative ATG/TLI conditioning for lymphomas.
Leuk Lymphoma;
63(1): 231-234, 2022 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34486920
8.
Publication outcomes of phase II oncology clinical trials.
Am J Clin Oncol;
32(3): 253-7, 2009 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-19349853